• Home
  • News
  • Business
  • Gear
  • Reviews
  • Games
  • Science
  • Security
Reading: The High-Stakes Race to Engineer New Psychedelic Drugs
Share
Ad image
Technology MagazineTechnology Magazine
Aa
  • News
  • Business
  • Gear
  • Reviews
  • Games
  • Science
  • Security
Search
  • Home
  • News
  • Business
  • Gear
  • Reviews
  • Games
  • Science
  • Security
Have an existing account? Sign In
Follow US
Technology Magazine > Science > The High-Stakes Race to Engineer New Psychedelic Drugs
Science

The High-Stakes Race to Engineer New Psychedelic Drugs

Press room
Press room Published July 26, 2022
Last updated: 2022/07/26 at 10:49 AM
Share
SHARE

“This is my life,” Wallach says. “There is nothing else I’d rather be doing. If I was given a billion dollars, today, the first thing I would do is build a superlab.” When Compass came calling, he finally got the golden opportunity to pursue that dream. Maybe not a full-blown, billion-dollar superlab. But a lab of his own.

In pop culture, psychedelia is a Day-Glo tapestry of mandalas, black-light inks, tie-dye, and phat pants embossed with lime-green alien heads. In their various states of synthesis and manufacture, psychoactive drugs are decidedly unkaleidoscopic: brownish, yellowish, and vaguely gross, like plaque scraped off nicotine-stained teeth. The labs where these drugs are synthesized smell as if someone were burning a Rotten Eggs Yankee Candle.

Last fall, I visited Wallach in his lab, where he was preparing some N,N-dipropyltryptamine—a legal, and extremely potent, hallucinogen. Dressed in a faded maroon polo, khakis, and chunky desert boots, Wallach sets up a reaction in a round-bottom flask while explaining that in the ’70s, scientists investigated DPT for use in psychotherapy. He flits around the lab, blasting out moisture from glassware, sealing tubes with argon gas, dissolving reagents in methanol, and advising me to keep my distance as he fiddles with substances that are, he warns, “fairly toxic.” It’s like watching a chef show off at a teppanyaki restaurant, slicing and dicing by pure reflex.

The fall semester is in session, and Wallach has returned, after the pandemic disruption, to in-class teaching. His lab—and its work for Compass—presses on. Wallach and his squad of mostly twentysomethings weave among a few different offices, testing compounds for purity, sketching out molecules in grid-lined notebooks, and preparing potentially mind-expanding substances in discreetly marked mailers to be sent for mouse-twitch tests at a partner lab at UC San Diego.

The job is to develop drugs that tickle the 5-HT2A receptor, a cellular protein involved in a range of functions—appetite, imagination, anxiety, sexual arousal. The receptor has proven crucial to understanding the neuropharmacology of the psychedelic experience induced by classical hallucinogens. LSD, mescaline, psilocybin—they all interact with 5-HT2A. (In certain circles, the phrase “5-HT2A agonist” has supplanted “psychedelic,” which still carries faint whiffs of hippie-era hedonism.) “If you’re designing a new version of a classical hallucinogen,” Wallach says, “the first thing you’re doing is looking at its interaction with that receptor.”

One of Wallach’s goals is to hack how long a psychedelic’s effect lasts. Full-dose psilocybin trips usually run in excess of six hours. Hand-me-down hippie wisdom dictates three full days for a proper LSD experience: one to prepare, one to trip, and one for reacclimating yourself to the world of waking, non-wiggly consciousness. From a clinical perspective, such epic sessions are expensive and may not be necessary. Meanwhile, drugs like DMT are acute and intense, with effects lasting only minutes (sometimes called “the businessman’s trip” because it can be enjoyed within a typical lunch hour). Finding what Compass cofounder Lars Wilde calls “the sweet spot” between the length of a trip and clinical efficacy is just one of Wallach’s many challenges. If he and his team of researchers happen upon a concoction that’s particularly potent or experientially unique—“cool” is a word that gets tossed around a lot—well, all the better.

Press room July 26, 2022
Share this Article
Facebook TwitterEmail Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Science

Gene Expression in Neurons Solves a Brain Evolution Puzzle

6 Min Read
Science

California’s Atmospheric Rivers Are Getting Worse

4 Min Read
Science

Can You Really Pump Water Without Any Electricity?

6 Min Read
Science

A Nonprofit Wants Your DNA Data to Solve Crimes

5 Min Read
  • Review
  • Top Lists
  • Contact
  • Privacy Policy
  • Terms of use

We influence 20 million users and is the number one business and technology news network on the planet.

I have read and agree to the terms & conditions

Contact US

  • Contact Us
  • DMCA
  • Editorial Policy
  • Advertise

Quick Link

  • Gear
  • Games
  • Security
  • Reviews

© 2022 Technology Magazine. All Rights Reserved.

Follow US on Socials

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?